Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 32818466

Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Sep
First author
Subbiah V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):e515. doi: 10.1016/S1470-2045(20)30554-4.
    note
    Source null
    related pmid
    33152306
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Nov;21(11):e516. doi: 10.1016/S1470-2045(20)30625-2.
    note
    Source null
    related pmid
    33152307
    relationship
    Comment in

Authors and identifiers

  1. name
    Subbiah V
    type
    Author
  2. name
    Lassen U
    type
    Author
  3. name
    Élez E
    type
    Author
  4. name
    Italiano A
    type
    Author
  5. name
    Curigliano G
    type
    Author
  6. name
    Javle M
    type
    Author
  7. name
    de Braud F
    type
    Author
  8. name
    Prager GW
    type
    Author
  9. name
    Greil R
    type
    Author
  10. name
    Stein A
    type
    Author
  11. name
    Fasolo A
    type
    Author
  12. name
    Schellens JHM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Subbiah V
    type
    Author
  2. name
    Lassen U
    type
    Author
  3. name
    Élez E
    type
    Author
  4. name
    Italiano A
    type
    Author
  5. name
    Curigliano G
    type
    Author
  6. name
    Javle M
    type
    Author
  7. name
    de Braud F
    type
    Author
  8. name
    Prager GW
    type
    Author
  9. name
    Greil R
    type
    Author
  10. name
    Stein A
    type
    Author
  11. name
    Fasolo A
    type
    Author
  12. name
    Schellens JHM
    type
    Author
bibliography ids
  1. nci-bib-cbe2940ed836aa020e979b19
book metadata
content sha256
a7540febaae8e5a0a2eba3a634945fdbacbe1a79593b97741ea0d4155bff9c0e
document type
citation
dois
  1. 10.1016/S1470-2045(20)30321-1
electronic publication date
display
2020 Aug 17
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32818466
immutable id
pubmed:32818466@a7540febaae8e5a0a2eba3a634945fdbacbe1a79593b97741ea0d4155bff9c0e
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1234-1243
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):e515. doi: 10.1016/S1470-2045(20)30554-4.
    note
    Source null
    related pmid
    33152306
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Nov;21(11):e516. doi: 10.1016/S1470-2045(20)30625-2.
    note
    Source null
    related pmid
    33152307
    relationship
    Comment in
outcomes validated
false
pmid
32818466
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
57a6737a44ba30351deac9d7d7ec0ddde66a1f8d238e5676b046d4160956cc45
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Sep
precision
month
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
  6. Research Support, U.S. Gov't, Non-P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32818466/
title
Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.

Preserved source evidence · Independent clinical review pending · Not medical advice